Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1456 (LINC01456) is a long intergenic non-coding RNA (lincRNA)—a subtype of long non-coding RNA (lncRNA) that is located between protein-coding genes and does not encode a protein[1][2]. Its gene is denoted as LINC01456, and it is expressed in certain tissues; however, its precise biological role is not well defined in the current literature. LincRNAs as a group can participate in chromatin modification, transcriptional regulation, and other genetic regulatory processes, but there is limited direct functional evidence for LINC01456. It has been identified as part of prognostic signatures in cancer studies, where its expression correlates with survival in some patient cohorts—but it is not a direct therapeutic target, nor does it interact with drugs or have a known mechanism of pharmacological action[4]. There is no evidence of confusion or misspelling regarding this target, but further literature may be needed for detailed biological and mechanistic insights.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1456 (LINC01456).